Alpine Woods Capital Investors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Sell
2,165
-132
-6% -$16.2K 0.06% 163
2026
Q1
$271K Sell
2,297
-3,839
-63% -$536K 0.07% 155
2025
Q4
$1.01M Buy
+6,136
New +$961K 0.24% 88

Other funds holding RGEN

Alpine Woods Capital Investors's RGEN Position: Q2 2026 in Review

Alpine Woods Capital Investors reduced its Repligen (RGEN) stake by 5.7% in Q2 2026, selling an estimated $16.2K and leaving 2,165 shares worth $295K. The position accounts for 0.06% of the portfolio, ranked #163.

Alpine Woods Capital Investors first reported a position in RGEN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.01M in Q4 2025. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Alpine Woods Capital Investors held 2,165 shares of Repligen worth $295K as of Q2 2026.
  • Alpine Woods Capital Investors sold 132 Repligen shares in Q2 2026, an estimated $16.2K.
  • Repligen made up 0.06% of Alpine Woods Capital Investors's portfolio in Q2 2026, its #163 holding.
  • Alpine Woods Capital Investors first reported a position in Repligen in Q4 2025 and has held it in 3 quarters since.
  • Alpine Woods Capital Investors's Repligen position peaked at $1.01M in Q4 2025.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.